Cargando…
Targeting Viral Ion Channels: A Promising Strategy to Curb SARS-CoV-2
SARS-CoV-2 is the etiological agent COVID-19, one of the most impactful health crises afflicting humanity in recent decades. While research advances have yielded several treatment and prevention options, the pandemic is slow to abate, necessitating an expansion of our treatment arsenal. As a member...
Autores principales: | Singh, Anamika, Arkin, Isaiah T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029588/ https://www.ncbi.nlm.nih.gov/pubmed/35455392 http://dx.doi.org/10.3390/ph15040396 |
Ejemplares similares
-
SARS-CoV-2 E protein is a potential ion channel that can be inhibited by Gliclazide and Memantine
por: Singh Tomar, Prabhat Pratap, et al.
Publicado: (2020) -
Blockers of the SARS-CoV-2 3a Channel Identified by Targeted Drug Repurposing
por: Tomar, Prabhat Pratap Singh, et al.
Publicado: (2021) -
Identification of SARS-CoV-2 E Channel Blockers from a Repurposed Drug Library
por: Tomar, Prabhat Pratap Singh, et al.
Publicado: (2021) -
Isolation thresholds for curbing SARS-CoV-2 resurgence
por: Yakob, Laith
Publicado: (2021) -
A SARS-CoV-2 antibody curbs viral nucleocapsid protein-induced complement hyperactivation
por: Kang, Sisi, et al.
Publicado: (2021)